Safety monitoring for ‘flu antivirals

July 7, 2009 at 9:56 am | In Prescribing Extra - Drugs | Print Print | No Comments

The Medicines and Healthcare products Regulatory Agency has announced the launch of a online reporting mechanism for monitoring the safety of the swine flu antiviral medicines.

It is expected that usage of oseltamivir (Tamiflu®) and zanamavir (Relenza®) will increase during the swine flu pandemic. The Swine ‘Flu ADR Portal can be used by healthcare professionals and the public to reported suspected adverse drug reactions (ADR) to either of these drugs.

Action: Clinicians should be aware of this portal and recommend it to patients with suspected ADRs. Clinicians should report adverse events for patients without internet access.

Copyright ©2009 Prescribing Advice for GPs

No Comments yet »

RSS feed for comments on this post. TrackBack URI

Leave a comment

XHTML: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS Feed for New Entries.
Akismet has protected Prescribing Advice for GPs from 5,974 spam comments.